Alnylam Pharmaceuticals Inc $71.25
|Trade Time:||Mar 14 11:24 AM Eastern Daylight Time|
|Change:||-0.73 (-1.01 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get ALNY Trend Analysis - it has outperformed the S&P 500 by 175%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|2/21/2014||Vaishnaw Akshay||EVP, Chief Medical Officer||-2,615||$90.10||-100.00%|
|2/19/2014||Reid Laurence||SVP, Chief Business Officer||10,000||$7.10||92.55%|
|2/19/2014||Reid Laurence||SVP, Chief Business Officer||3,500||$15.99||16.82%|
|2/19/2014||Reid Laurence||SVP, Chief Business Officer||-3,079||$78.62||-12.67%|
|2/19/2014||Reid Laurence||SVP, Chief Business Officer||-11,465||$80.02||-54.01%|
ALNY Stock Analysis
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!